Specialty code 174400000X · Baton Rouge, LA
NPI
1881709657
Since 2006
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
9808 Bluebonnet Blvd, Ste 200
Baton Rouge, LA, 70810
Phone (225) 763-9050
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
4,788 prescriptions
Company payments, 2025
$81.32
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Rajat Bhushan prescribed most often to Medicare patients was Ozempic (Semaglutide), with 208 prescriptions and refills. In total Rajat Bhushan wrote 4,788 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 208 | 251 | 28 | $238K |
| Synthroid Levothyroxine Sodium | 193 | 379 | 40 | $17K |
| Rosuvastatin Calcium Generic | 166 | 321 | 33 | $2,265 |
| Mounjaro Tirzepatide | 152 | 163 | 20 | $166K |
| Clonazepam Generic | 149 | 171 | 23 | $1,607 |
| Levothyroxine Sodium Generic | 129 | 349 | 31 | $891 |
| Ezetimibe Generic | 125 | 239 | 28 | $2,554 |
| Atorvastatin Calcium Generic | 95 | 227 | 23 | $667 |
| Amlodipine Besylate Generic | 87 | 215 | 23 | $503 |
| Omeprazole Generic | 82 | 141 | 14 | $772 |
| Farxiga Dapagliflozin Propanediol | 81 | 135 | 15 | $75K |
| Bupropion Xl Bupropion Hcl | 74 | 138 | 16 | $2,151 |
| Montelukast Sodium Generic | 67 | 128 | 13 | $665 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 67 | 91 | Under 11 | $36K |
| Tamsulosin Hcl Generic | 64 | 116 | 12 | $583 |
Brand drugs: 1,439 claims; generic drugs: 3,259 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajat Bhushan $81.32 ($81.32 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $56.09.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.